Bioavailability (F)

Build intuition for bioavailability and understand why administered dose is not always equal to systemic exposure.
Tip

What you’ll build today: intuition for how much drug actually reaches circulation and why dose does not automatically equal exposure.

Learning Objectives

By the end of this lesson, you will be able to:

  • Define bioavailability conceptually
  • Explain how bioavailability affects exposure
  • Distinguish amount entering from rate of entry
  • Interpret low vs high bioavailability correctly

Key Ideas

Bioavailability describes:

how much of the administered dose reaches systemic circulation

Bioavailability is often represented as:

\[ F \]

Conceptually:

\[ \text{Systemic Amount}=F\times Dose \]

where:

  • larger \(F\) → more drug reaches circulation
  • smaller \(F\) → less drug reaches circulation

Insight: Bioavailability determines how much gets in, not how quickly it gets in.

Warning

Low bioavailability does not necessarily mean slow absorption.

A drug may enter quickly but only a small fraction may ultimately reach circulation.

Why Bioavailability Matters

After administration:

  • not all drug necessarily enters circulation
  • some may not absorb
  • some may be lost before reaching systemic circulation

That means:

Dose administered ≠ dose reaching circulation

This distinction is fundamental in pharmacometrics.

Worked Example: Same Dose, Different Bioavailability

Imagine two patients receive the same oral dose.

  • Patient A → high bioavailability
  • Patient B → low bioavailability

What happens?

  • Patient A → greater exposure
  • Patient B → lower exposure

The administered dose is identical.

But the amount entering circulation differs.

Notice:

  • timing remains similar
  • profile shape remains similar
  • total exposure changes

Expanding the Example

Now compare another familiar scenario.

Intravenous administration:

\[ F=1 \]

Oral administration:

\[ F<1 \]

flowchart TB

D[Dose]

D --> A[Absorption]

A --> F[Fraction reaches circulation]

F --> C[Observed concentration]

Not all administered drug necessarily becomes observable in plasma.

This means:

  • dose alone does not determine exposure
  • bioavailability changes how much exposure is possible

Clinical Interpretation

Bioavailability helps explain:

  • differences between oral and IV administration
  • formulation differences
  • food effects
  • variability across products
  • differences in exposure despite equal dose

It is especially important for:

  • comparing formulations
  • interpreting exposure differences
  • understanding oral dosing

Insight

A useful mental model:

Absorption rate determines how quickly drug arrives.
Bioavailability determines how much drug arrives.

Note

Always ask:

“Is exposure changing because less drug entered—or because drug entered more slowly?”

Strategies

  • Separate amount entering from timing of entry
  • Compare exposure across routes
  • Interpret low exposure cautiously
  • Ask whether bioavailability or elimination explains the observation

Common Mistakes

  • Assuming administered dose equals systemic exposure
  • Confusing bioavailability with absorption rate
  • Treating low concentration as low dose
  • Ignoring route of administration

Practice Problems

  1. What does bioavailability represent?
  2. Does lower bioavailability mean slower absorption?
  3. Why can two patients receiving the same dose show different exposure?
  1. The fraction of administered dose reaching circulation
  2. No—amount and timing are different concepts
  3. Because different fractions of dose may reach circulation

Summary

Bioavailability determines:

  • how much drug reaches circulation
  • how much exposure is possible
  • why dose does not equal systemic amount

Understanding bioavailability helps separate:

  • administered dose
  • delivered dose
  • observed exposure
  • F controls amount entering
  • Dose ≠ systemic amount
  • Faster absorption ≠ higher F
  • Exposure depends on delivered amount
  • Always separate amount from timing